PRMT1 Is Recruited via DNA-PK to Chromatin Where It Sustains the Senescence-Associated Secretory Phenotype in Response to Cisplatin.
Protein arginine methyltransferase 1 (PRMT1) is overexpressed in various human cancers and linked...
Read More
Hematology/Oncology
Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on.
Patients with advanced epithelial ovarian cancer have a high incidence of peritoneal disease...
Read More
Treatment of recurrent epithelial ovarian cancer.
The majority of patients with advanced ovarian cancer progress after first-line therapy and...
Read More
Surgery in recurrent ovarian cancer.
Ovarian cancer is one of the most challenging diseases in gynecologic oncology. The presentation...
Read More
New strategies in ovarian cancer treatment.
Insights from basic science dissecting carcinogenesis in the fallopian tube and ovary have led to...
Read More
Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer.
Despite its widespread use, until recently, there was no randomized evidence for hyperthermic...
Read More